Calreticulin and type I interferon: An unsuspected connection

Calreticulin and type I interferon: An unsuspected connection

Bibliographic Details
Main Authors:	Lorenzo Galluzzi, Guido Kroemer
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-03-01
Series:	OncoImmunology
Subjects:	acute myeloid leukemia atp cd8+ cytotoxic t lymphocytes dendritic cells hmgb1 immunogenic cell death
Online Access:	http://dx.doi.org/10.1080/2162402X.2017.1288334

Similar Items

Dynamical Boolean Modeling of Immunogenic Cell Death
by: Andrea Checcoli, et al.
Published: (2020-11-01)

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
by: Lenka Kasikova, et al.
Published: (2019-11-01)

Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
by: Darina Ocadlikova, et al.
Published: (2019-10-01)

Metabolic enzymes expressed by cancer cells impact the immune infiltrate
by: Gautier Stoll, et al.
Published: (2019-06-01)

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
by: Heinrich B, et al.
Published: (2017-05-01)

CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
by: Rosanna Mezzapelle, et al.
Published: (2021-06-01)

Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death
by: Chi-Chao Liu, et al.
Published: (2019-05-01)

Secreted calreticulin mutants subvert anticancer immunosurveillance
by: Peng Liu, et al.
Published: (2020-01-01)

Calreticulin arms NK cells against leukemia
by: Jitka Fucikova, et al.
Published: (2020-01-01)

ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
by: Mariangela Lecciso, et al.
Published: (2017-12-01)

A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
by: Darina Ocadlikova, et al.
Published: (2020-09-01)

FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin
by: Jonathan G. Pol, et al.
Published: (2020-01-01)

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients
by: Iva Truxova, et al.
Published: (2018-12-01)

Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner
by: Pei-Ming Yang, et al.
Published: (2020-04-01)

The grand challenges to cellular and molecular oncology
by: Lorenzo eGalluzzi, et al.
Published: (2011-03-01)

Calreticulin couples with immune checkpoints in pancreatic cancer
by: Xing Huang, et al.
Published: (2020-03-01)

Autophagy : A New Modulator of Immunogenic Cell Death for Cancer Therapy
by: Sukkurwala, Abdul Qader
Published: (2013)

Past, present and future of molecular and cellular oncology
by: Lorenzo eGalluzzi, et al.
Published: (2011-03-01)

Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
by: Rianne D. W. Vaes, et al.
Published: (2021-04-01)

Effects of dendritic cell vaccine activated with protein components of toxoplasma gondii on tumor specific CD8+ T-cells
by: Amari A, et al.
Published: (2009-12-01)

The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8<sup>+</sup> T Cell Responses
by: Cheol Gyun Kim, et al.
Published: (2019-11-01)

CYTOTOXIC ACTIVITY OF DENDRITIC CELLS AGAINST ACTIVATED CD4+ AND CD8+T-LYMPHOCYTES IN THE CULTURE IN VITRO
by: T. V. Tyrinova, et al.
Published: (2012-05-01)

An epigenetic modifier triggers therapeutic immune responses against breast cancer
by: Lorenzo Galluzzi, et al.
Published: (2017-05-01)

Therapeutic implications of immunogenic cell death in human cancer
by: Fabio ePalombo, et al.
Published: (2014-01-01)

Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines
by: Lien eVandenberk, et al.
Published: (2016-01-01)

Anaplasma phagocytophilum-Related Defects in CD8, NKT, and NK Lymphocyte Cytotoxicity
by: Diana G. Scorpio, et al.
Published: (2018-04-01)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
by: Heleen H. Van Acker, et al.
Published: (2019-04-01)

Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells
by: Yanke Zhang, et al.
Published: (2019-10-01)

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia
by: Ramin Radpour, et al.
Published: (2021-05-01)

Clonal Upregulation of Effector Cytotoxic T Lymphocytes in a Patient with Multiple Tyrosine Kinase Inhibitor-Refractory Chronic Myeloid Leukemia with Long-Term Survival
by: Tatsuro Jo, et al.
Published: (2021-03-01)

Calreticulin—Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients
by: Michal Kielbik, et al.
Published: (2021-01-01)

Non-Thermal Plasma Application in Tumor-Bearing Mice Induces Increase of Serum HMGB1
by: Olga Troitskaya, et al.
Published: (2020-07-01)

Peripheral Blood Lymphocyte Subsets (CD4+, CD8+ T Cells, NK Cells) in Patients with Cardiovascular and Neurological Complications after Carotid Endarterectomy
by: Katarzyna Kotfis, et al.
Published: (2015-05-01)

FEATURES OF IMMUNOCOMPETENT CELLS IN THE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT PRIMARY DIAGNOSIS
by: N. V. Isaeva, et al.
Published: (2016-01-01)

Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells
by: Yingting Liu, et al.
Published: (2019-04-01)

ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity
by: Cinthia Silva-Vilches, et al.
Published: (2018-11-01)

Radiotherapy effects on anti-tumor immunity: implications for cancer treatment.
by: Sandra eDemaria, et al.
Published: (2013-05-01)

Tumor-intrinsic determinants of immunogenic cell death modalities
by: Samuel T Workenhe, et al.
Published: (2021-01-01)

Activation of CD4 and CD8 T cell receptors and regulatory T cells in response to human proteins
by: Borros M. Arneth
Published: (2018-03-01)

CD1c-related DCs that express CD207/langerin, but are distinguishable from Langerhans cells, are consistently present in human tonsils
by: Anne eDe Monte, et al.
Published: (2016-05-01)